Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

A new vaccine strategy against serogroup b meningococcal infection: from antigen discovery to clinical trials

De 2000-02-01 à 2003-04-01

Détails concernant le projet

Coût total:

EUR 3 687 024

Contribution de l'UE:

EUR 2 640 000

Coordonné à/au(x)/en:

Belgium

Régime de financement:

CSC - Cost-sharing contracts

Objectif

Coordinateur

GLAXOSMITHKLINE BIOLOGICALS SA
Belgium
Rue de l'Institut 89
--- RIXENSART
Belgium
Contact administratif: Jean-Paul PRIEELS

Participants

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
Rue de Tolbiac, 101
75654 PARIS
France
See on map
Contact administratif: Claude GRISCELLI
Fax: +30-2610997848
KAROLINSKA INSTITUTE
Sweden
Solnavagen 1
171 77 STOCKHOLM
Sweden
See on map
Contact administratif: Heather MARSHALL-HEYMAN
E-mail
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Germany
Hofgartenstrasse 8
MUENCHEN
Germany
See on map
Contact administratif: Hans LEHRACH
E-mail
MICROBIOLOGICAL RESEARCH AUTHORITY
United Kingdom
Porton Down
SP4 0JG SALISBURY
United Kingdom
Contact administratif: Michael HARKER
NATIONAL BIOLOGICAL STANDARDS BOARD
United Kingdom
Blanche lane, South Mimms
POTTERS BAR
United Kingdom
Contact administratif: Richard STEWART
NORWEGIAN INSTITUTE OF PUBLIC HEALTH
Norway
75,Geitmyrsveien 75 Torshov
0403 OSLO
Norway
See on map
Contact administratif: Bodolf HAREIDE
THE NATIONAL HOSPITAL UNIVERSITY OF OSLO
Norway
Pilestredet 32
0027 OSLO
Norway
See on map
Contact administratif: Inger STRAY LIEN
WISE & MUNRO LEARNING RESEARCH
Netherlands
8,Azaleastraat 85
2565 CD DEN HAAG
Netherlands
See on map
Contact administratif: Hans AMESZ